Reuters logo
BRIEF-Zealand starts Phase IIa clinical trial with dasiglucagon in dual-hormone artificial pancreas system from Beta Bionics
December 13, 2016 / 7:31 AM / in 10 months

BRIEF-Zealand starts Phase IIa clinical trial with dasiglucagon in dual-hormone artificial pancreas system from Beta Bionics

Dec 13 (Reuters) - Zealand Pharma A/S :

* Initiates Phase IIa clinical trial with dasiglucagon in a dual-hormone artificial pancreas system from Beta Bionics

* In December, Zealand initiated two Phase IIa trials, to test dasiglucagon’s potential in a dual-hormone artificial pancreas system

* Results from both trials are expected in H1 2017 Source text for Eikon: Further company coverage: (Gdynia Newsroom)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below